2cureX
1.11 SEK
+3.55 %
Less than 1K followers
2CUREX
First North Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Valuation
Income statement
Income statement
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for 2cureX
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | 0.1 | 0.2 | |||||
| growth-% | 77.8 % | ||||||
| EBITDA | -8.3 | -7.0 | -22.4 | -31.8 | -34.4 | -4.7 | - |
| EBIT | -8.7 | -7.4 | -22.8 | -32.1 | -34.7 | -4.7 | -2.8 |
| Profit before taxes | -9.4 | -8.6 | -22.5 | -29.8 | -35.5 | -4.1 | -2.6 |
| Net income | -7.9 | -7.3 | -18.9 | -29.8 | -30.8 | -4.1 | -2.6 |
| EPS | -0.70 | -0.49 | -1.15 | -1.69 | -1.72 | -0.13 | -0.10 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend ratio | -0.0 % | -0.0 % | -0.0 % | -0.0 % | -0.0 % | -0.0 % | -0.0 % |
Profitability and return on capital
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| EBITDA-% | -35,355.6 % | -21,487.5 % | |||||
| EBIT-% | -35,700.0 % | -21,687.5 % | |||||
| ROE | -28.3 % | -12.4 % | -25.5 % | -69.2 % | -225.1 % | -81.0 % | 7,250.0 % |
| ROI | -21.0 % | -11.6 % | -23.9 % | -62.5 % | -185.3 % | -53.3 % | -124.5 % |